Ron Davidson

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.

NexSig Neurological Examination Technologies Ltd. is engaged in the provision of diagnostic system for neurological disorder detection, primarily Alzhemeir's disease. Its product, NexAde, is a system that measures and analyzes biometric signals through self-administered computerized tests. The company was founded by Vered Aharonson and Amos D. Korczyn in May 2004 and is headquartered in Herzlia, Israel.